Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03KVY
|
|||
| Former ID |
DIB006058
|
|||
| Drug Name |
BCT303
|
|||
| Synonyms |
Liothyronine sustained release
Click to Show/Hide
|
|||
| Indication | Hypothyroidism [ICD-11: 5A00; ICD-10: E03.8, E03.9; ICD-9: 244] | Phase 2 | [1] | |
| Company |
Intellectual property executives
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Thyroid hormone receptor alpha (THRA) | Target Info | Modulator | [2] |
| Thyroid hormone receptor beta (THRB) | Target Info | Modulator | [2] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Thyroid hormone signaling pathway | ||||
| Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | |||
| Reactome | Nuclear Receptor transcription pathway | |||
| WikiPathways | Endochondral Ossification | |||
| Nuclear Receptors | ||||
| SIDS Susceptibility Pathways | ||||
| Hematopoietic Stem Cell Differentiation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037654) | |||
| REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.